Thus, four distinct subtypes of SCLC defined by the predominant transcriptional regulatory mechanism operating in cancer cells have been described on the basis of the expression of ASCL1, NEUROD1, YAP1, and POU2F346. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.